SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Democratic gains and the prospect of party control of Congress are driving attention to DJT, as traders view the results as a political setback for Trump and a potential loss of political tailwind for the company. Community reaction is overwhelmingly bearish, though some argue Trumps veto power and a gridlocked government could limit the impact.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Democratic gains in the midterm elections are the focus as SPY sharply reversed an overnight selloff; traders cite relief over divided-government gridlock and reduced uncertainty, while others worry about AI and data-center regulation and lingering oil and Iran risks. Bulls point to dip-buying and a possible short squeeze, while skeptics call the rebound volatile and potentially temporary.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs stronger-than-expected results and upbeat outlook, powered by AI and data-center demand, drove the conversation and an initial post-earnings surge. Bulls focused on accelerating growth, while skeptics questioned the valuation and cash flow and worried that political pushback could slow data-center expansion; the stocks sharp swings fueled debate over whether the gains would hold.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Democratic midterm gains have sparked concern that congressional scrutiny could affect SpaceXs government contracts and data-center expansion, with traders also debating whether Musks political involvement could complicate a potential Tesla-SpaceX merger. Bearish calls about lasting regulatory and contract risks compete with dip-buyers who view the selloff as an overreaction and argue the companys long-term business prospects remain intact.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros strong quarterly results and raised outlook, driven by AI-server demand, are the main focus. Bulls see the growth as evidence the AI buildout remains robust, while skeptics point to thin margins, cash-flow concerns and lingering credibility issues; election-related fears about data-center oversight are also cited as a drag on the muted share reaction.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers quarterly results modestly topped estimates, but traders are focused on the forward outlook and the stocks muted-to-weak reaction, with some calling the guidance soft despite growth and profitability gains. The broader debate centers on persistent share-price weakness and whether autonomous-vehicle competition threatens Ubers platform or could become a growth opportunity through partnerships.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Democratic gains in the midterms sparked sharp swings in QQQ, with traders debating whether the initial selloff and subsequent rebound signal relief as political uncertainty fades or renewed risk. Some see divided government as supportive for markets, while others worry that tighter AI and data-center rules could weigh on tech stocks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCrysts quarterly results beat expectations, with higher full-year total-revenue guidance and FDA approval of ORLADEYO oral pellets for patients 12 and older. Traders welcomed the report but debated whether ORLADEYO sales were boosted by a pharmacy inventory build, noting that its own revenue guidance was unchanged.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds quarterly results are driving attention, with traders weighing an earnings beat against a revenue miss and mixed regional sales trends. Reactions are divided between those calling the results solid, particularly on U.S. comparable sales, and those waiting to see whether the revenue shortfall or management commentary weighs on shares.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Traders are focused on reported Democratic gains in Congress and Texas, which they fear could bring greater scrutiny of Musks companies, government ties, and a potential SpaceX merger. The reaction is largely bearish, though some see possible support from pro-EV policies or view the pullback as a buying opportunity; merger outcomes remain speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of -22.73% and +35.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?

LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.

EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?

EyePoint (EYPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?

Liquidia Corporation (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure  

Equity

Growth prospects, business challenges, legal changes, and rising competition from SpaceX shaped Wall Street activity this week.

Wall Street’s Next Movers

The market is serving up a powerful mix of movers, including Alaunos Therapeutics (NASDAQ:TCRT) completed a major acquisition backed by a $350 million private placement, while NeOnc Technologies Holdings (NASDAQ:NTHI) is preparing for an important FDA discussion. Verastem Oncology (NASDAQ:VSTM) reported fresh cancer-drug results alongside a major financing and leadership transition, and Liquidia (NASDAQ:LQDA) resolved a prolonged legal battle over its pulmonary-hypertension treatment. Bending Spoons (NASDAQ:BSP) is attracting another major investment from Berkshire Hathaway.

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Liquidia settles six legal disputes with United Therapeutics, securing Yutrepia access for PAH patients but facing $380.7 million in payments and a narrower drug label.

LQDA Stock Rockets 40% Today – BTIG Calls United Therapeutics Settlement ‘Better Than Best-Case Scenario’

LifeSci Capital said the agreement removes a major obstacle that could have discouraged potential buyers from pursuing an acquisition of Liquidia.


Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday

U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire's $330M investment. Liquidia and Verastem also posted strong gains.read more...

Dow Futures Rise, Nasdaq Subdued Premarket Ahead Of Inflation Data: ASML, MU, SKHY, TSLA, BAC, LQDA, GME, IREN Stocks In Focus

On Stocktwits, retail sentiment toward SPY and QQQ has remained ‘bullish’ ahead of the CPI print. 


Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Bearish Sentiment

<ul class="summary-bullets"><li>Crocs stock rose 8.5% this week as Barclays upgraded it to ‘Overweight’ from ‘Equal Weight’.</li><li>Liquidia stock surged 27% this week, its strongest since May, after settling six lawsuits with United Therapeutics.&nbsp;</li><li>Albertsons faced downgrades after its Q2 results, as concerns grew over operational hurdles.&nbsp;</li></ul><p>Wall Street analysts warmed to Crocs Inc. (CROX) and Liquidia Corp. (LQDA) on growth potential and easing legal risks, while Albertsons Companies (ACI) faced downgrades from three firms. Meanwhile, SpaceX’s growing ambitions rattled sentiment around AT&amp;T (T) and AST SpaceMobile (ASTS), triggering concerns over telecom competition and satellite launch plans.&nbsp;</p><h2 class="st-heading-2">Product Momentum Supports Crocs Upgrade</h2><p><a href="https://stocktwits.com/symbol/CROX">Crocs stock</a> gained 8.5% this week as the company received an upgrade to ‘Overweight’ from ‘Equal Weight’ at Barclays, which increased its price target to $139 from $118. The firm sees a clearer route to expansion over the coming years.</p><p>Barclays believes improving conditions across the business could help Crocs move past a period of uneven performance. Although its North American operations continue to face short-term challenges, investments in new products, additional categories, and brand development appear to be supporting demand. International operations are already generating sales growth.</p><p>Last month, Crocs CFO Patraic Reagan said footwear demand naturally rises and falls every few years, but Crocs is reducing its reliance on classic clogs by expanding into sandals, ballet flats, recovery shoes and other styles. Its sandal business generates nearly $500 million annually. The company is also expanding HEYDUDE into products for activities like boating, fishing and work.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_043744873_5d87402f2b.png" alt="koyfin_20261016_043744873.png" width="2400" height="1240"></figure><h2 class="st-heading-2">Legal Settlement Lifts Liquidia Outlook</h2><p><a href="https://stocktwits.com/symbol/LQDA">Liquidia stock</a> has climbed 27% and is on track for its best week since May after it won upgrades from LifeSci Capital and BTIG after reaching an agreement with United Therapeutics Corp. (UTHR) that resolves six outstanding lawsuits between the companies.</p><p>LifeSci Capital analyst Gaurav Maini raised Liquidia to ‘Outperform’ from ‘Market Perform’ and established a $59 price target. The firm believes the agreement removes a major source of uncertainty, allowing Yutrepia to remain available for pulmonary arterial hypertension while removing its use for pulmonary hypertension associated with interstitial lung disease from the label. The settlement could also make Liquidia more attractive to potential strategic partners or buyers.</p><p>Separately, BTIG moved to ‘Buy’ from ‘Neutral’ and set a $70 target. The firm viewed the settlement terms more positively than it had expected before the announcement.</p><h2 class="st-heading-2">Array Technologies Draws Contrarian Interest</h2><p><a href="https://stocktwits.com/symbol/ARRY">Array Technologies stock</a> was upgraded to ‘Outperform’ from ‘Neutral’ by Mizuho, even as the firm cut its price target to $5 from $7. The stock has dropped 61% this year, but the analyst sees room for gains compared with the risk of further losses.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_044341010_b622791540.png" alt="koyfin_20261016_044341010.png" width="2400" height="1240"></figure><p>Mizuho believes investors are too worried about weaker demand and the company’s need for cash. The firm expects business to improve in 2027, supported by existing orders and acquisitions that could help cut costs and improve efficiency. It also expects sales and profit margins to outperform market forecasts.&nbsp;</p><h2 class="st-heading-2">Albertsons Faces Multiple Analyst Downgrades</h2><p><a href="https://stocktwits.com/symbol/ACI">Albertsons Companies stock</a> faced three analyst downgrades this week after its fiscal second-quarter results, as concerns grew over its business plan and financial outlook.</p><p>JPMorgan lowered its rating to ‘Neutral’ from ‘Overweight’ but kept its $14 price target unchanged. Although Albertsons shares are cheaper than those of many U.S. grocery rivals, the firm believes ongoing business challenges and weaker-than-expected cost-cutting efforts may explain the lower valuation.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_044948856_fe781ba6d5.png" alt="koyfin_20261016_044948856.png" width="2400" height="1240"></figure><p>Goldman Sachs and Bank of America downgraded Albertsons and cut their price targets, citing uncertainty about the company’s growth plans and a suspended 2026 forecast. The analysts expect the stock to remain in a narrow range until management provides more details on its growth plans after completing a business review by spring 2027.</p><h2 class="st-heading-2">SpaceX Competition Clouds AT&amp;T,&nbsp; AST SpaceMobile Prospects</h2><p><a href="https://stocktwits.com/symbol/T">AT&amp;T stock</a> was downgraded to ‘Market Perform’ from ‘Outperform’ by Bernstein, which lowered its price target to $24 from $25. The analyst sees growing competition from SpaceX across broadband and wireless services as an additional challenge for established telecom providers.</p><p>Bernstein also cited recent pricing decisions by incumbent carriers and the possibility of seasonal weakness in the fourth quarter.&nbsp;<a href="https://stocktwits.com/symbol/ASTS">AST SpaceMobile stock</a> was downgraded to ‘Neutral’ from ‘Overweight’ at Piper Sandler, which cut its price target to $54 from $98. The firm has less confidence in the company's planned satellite deployment pace in 2026 and 2027.</p><p>SpaceX’s $8 billion purchase of mobile spectrum last week has raised concerns about competition in satellite-based phone services. Piper warned that SpaceX could limit rocket launch access for partners like AST SpaceMobile, delaying the company’s satellite deployment plans.&nbsp;</p><p>So far this year, CROX and LQDA have gained 0.8% and 45%, respectively, while ARRY, ACI, T and ASTS stocks have declined between 5% and 61%.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aa-stock-rises-overnight-alcoa-ceo-bets-on-massena-east-for-cash-pump-as-alumina-market-tightens/cZx0w5uRBs2">AA Stock Rises Overnight: Alcoa CEO Bets On Massena East For Cash Pump As Alumina Market Tightens</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A Crocs logo sign is seen in New York City, United States.

Wall Street analysts warmed to Crocs Inc. (CROX) and Liquidia Corp. (LQDA) on growth potential and easing legal risks, while Albertsons Companies (ACI) faced downgrades from three firms. Meanwhile, SpaceX’s growing ambitions rattled sentiment around AT&T 

Feed

News

Sentiment

Earnings

Fundamentals

Info

LQDA News